Fintel reports that on November 6, 2024, TD Cowen upgraded their outlook for Clorox (NYSE:CLX) from Sell to Hold. Analyst ...

RBC Capital analyst Nik Modi maintained a Hold rating on Clorox (CLX – Research Report) on October 31 and set a price target of $150.00.

Get Our Latest Analysis on CLX Clorox Trading Down 0.1 % Shares of Clorox stock opened at $162.37 on Wednesday. The firm has a market cap of $20.10 billion, a PE ratio of 56.57, a P/E/G ratio of 3 ...

Clorox (NYSE:CLX – Free Report) had its price objective raised by Barclays from $137.00 to $139.00 in a report issued on Friday, Benzinga reports.The firm currently has an underweight rating on ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

Bengaluru-based deeptech startup CynLr (Cybernetics Laboratory) raised $10 million in Series A funding in a round led by ...

This valuable study reveals extensive binding of eukaryotic translation initiation factor 3 (eIF3) to the 3' untranslated regions (UTRs) of efficiently translated mRNAs in human pluripotent stem ...

For example, the SPY (Nov. 15) at-the-money straddle costs about 19 points. That is roughly what the marketplace is expecting SPY to move (or 190 S&P 500 points). So if SPY were at 578, then you would ...

As of October 25 at 10:12 a.m. EDT. Market Open.

As of October 31 at 10:43 a.m. EDT. Market Open.